Grand Pharmaceutical Group Limited, also known as 远大医药集团有限公司, is a technology-driven international pharmaceutical company based in Hong Kong. The company specializes in pharmaceutical technology, nuclear medicine for cancer treatment, precision intervention for cardiovascular and cerebrovascular diseases, and biotechnology. In 2002, Grand Pharmaceutical Group Limited underwent a change in its equity structure, leading to its indirect listing on the Hong Kong Stock Exchange. The company currently owns more than 30 subsidiary companies, which include divisions for respiratory and critical care anti-infection, oncology, cardiovascular emergency care, ophthalmology, precision intervention for cardiovascular and cerebrovascular diseases, nuclear medicine for cancer treatment, and high-quality amino acids.
Headquarters
Unit 3302, The Centre, 99 Queen'S Road, Hong Kong
Hong Kong; Hong Kong;
Contact Details: Purchase the Grand Pharmaceutical Group Limited report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service